{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:14:19Z","timestamp":1790820859521,"version":"4.1.0"},"reference-count":44,"publisher":"BMJ","issue":"2","funder":[{"DOI":"10.13039\/501100006451","name":"Hospices Civils de Lyon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006451","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2018,11,7]]},"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Immune reconstitution after haematopoietic stem cell transplantation (HSCT) is a complex and dynamic process, varying from a state of nearly complete immunosuppression to an expected full immune recovery. Specific vaccination guidelines recommend reimmunisation after HSCT but data regarding vaccine efficacy in this unique population are scarce. New immune functional assays could enable prediction of vaccine response in the setting of HSCT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>\n                      A prospective, longitudinal single-centre cohort study of autologous and allogeneic HSCT recipients was designed in order to determine the vaccine response to five vaccine targets (pneumococcus, hepatitis B virus,\n                      <jats:italic>Haemophilus Influenzae<\/jats:italic>\n                      type b, tetanus and diphtheria) and to correlate it to immune function parameters. A workflow was set up to study serological response to vaccines and to describe the functional immune status of 100 HSCT recipients (50 autologous and 50 allogeneic) before and 3, 12 and 24 months after primary immunisation. At each time point, \u2018basic\u2019 immune status recording (serology, immunophenotyping of lymphocyte subsets by flow cytometry) will be assessed. The immune response will furthermore be evaluated before and 3 months after primary vaccination by two ex vivo immune functional assays assessing: (1) tumour necrosis factor alpha, interferon gamma production and host messenger RNA expression on whole-blood stimulation by lipopolysaccharide or\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      enterotoxin B and (2) T-lymphocyte proliferation in response to a standard mitogen (phytohaemagglutinin) or to selected recall antigens. Reference intervals will be determined from a cohort of 30 healthy volunteers. This translational study will provide data describing vaccine response, immune functionality of HSCT recipients over time and will allow mapping HSCT recipients with regard to their immune function.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethical approval has been obtained from the institutional review board (no 69HCL17_0769). Results will be communicated at scientific meetings and submitted for publication in peer-reviewed journals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"NCT03659773\" ext-link-type=\"clintrialgov\" specific-use=\"clinicaltrial pre-results\">NCT03659773<\/jats:ext-link>\n                      ; Pre-results.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2018-026093","type":"journal-article","created":{"date-parts":[[2019,2,16]],"date-time":"2019-02-16T04:49:25Z","timestamp":1550292565000},"page":"e026093","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":12,"title":["VaccHemInf project: protocol for a prospective cohort study of efficacy, safety and characterisation of immune functional response to vaccinations in haematopoietic stem cell transplant recipients"],"prefix":"10.1136","volume":"9","clinical-trial-number":[{"clinical-trial-number":"nct03659773","registry":"10.18810\/clinical-trials-gov","type":"preResults"}],"author":[{"given":"Anne","family":"Conrad","sequence":"first","affiliation":[{"name":"D\u00e9partement des Maladies Infectieuses et Tropicales, Hospices Civils de Lyon, Lyon, France"},{"name":"CIRI-Centre International de Recherche en Infectiologie, Inserm U1111, Universit\u00e9 Claude Bernard Lyon, CNRS, UMR5308, Ecole Normale Sup\u00e9rieure de Lyon, Univ Lyon, Lyon, France"},{"name":"Universit\u00e9 Claude Bernard Lyon I, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Boccard","sequence":"additional","affiliation":[{"name":"D\u00e9partement des Maladies Infectieuses et Tropicales, Hospices Civils de Lyon, Lyon, France"},{"name":"CIRI-Centre International de Recherche en Infectiologie, Inserm U1111, Universit\u00e9 Claude Bernard Lyon, CNRS, UMR5308, Ecole Normale Sup\u00e9rieure de Lyon, Univ Lyon, Lyon, France"},{"name":"Universit\u00e9 Claude Bernard Lyon I, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Valour","sequence":"additional","affiliation":[{"name":"D\u00e9partement des Maladies Infectieuses et Tropicales, Hospices Civils de Lyon, Lyon, France"},{"name":"CIRI-Centre International de Recherche en Infectiologie, Inserm U1111, Universit\u00e9 Claude Bernard Lyon, CNRS, UMR5308, Ecole Normale Sup\u00e9rieure de Lyon, Univ Lyon, Lyon, France"},{"name":"Universit\u00e9 Claude Bernard Lyon I, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Alcazer","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Claude Bernard Lyon I, Lyon, France"},{"name":"D\u00e9partement d\u2019H\u00e9matologie Clinique, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aydee-Tamara","family":"Tovar Sanchez","sequence":"additional","affiliation":[{"name":"Service d\u2019Hygi\u00e8ne, Epid\u00e9miologie, Infectiovigilance et Pr\u00e9vention, Hospices Civils de Lyon, Lyon, France"},{"name":"\u00c9quipe \u00c9pid\u00e9miologie et Sant\u00e9 Internationale, Laboratoire des Pathog\u00e8nes \u00c9mergents, Fondation M\u00e9rieux, Centre International de Recherche en Infectiologie, Inserm U1111, Centre National de la Recherche Scientifique Unit\u00e9 Mixte de Recherche 5308, Ecole Nationale Sup\u00e9rieure de Lyon, Universit\u00e9 Claude Bernard Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Chidiac","sequence":"additional","affiliation":[{"name":"D\u00e9partement des Maladies Infectieuses et Tropicales, Hospices Civils de Lyon, Lyon, France"},{"name":"Universit\u00e9 Claude Bernard Lyon I, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Laurent","sequence":"additional","affiliation":[{"name":"D\u00e9partement des Maladies Infectieuses et Tropicales, Hospices Civils de Lyon, Lyon, France"},{"name":"CIRI-Centre International de Recherche en Infectiologie, Inserm U1111, Universit\u00e9 Claude Bernard Lyon, CNRS, UMR5308, Ecole Normale Sup\u00e9rieure de Lyon, Univ Lyon, Lyon, France"},{"name":"Universit\u00e9 Claude Bernard Lyon I, Lyon, France"},{"name":"Institut des Agents Infectieux, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Vanhems","sequence":"additional","affiliation":[{"name":"CIRI-Centre International de Recherche en Infectiologie, Inserm U1111, Universit\u00e9 Claude Bernard Lyon, CNRS, UMR5308, Ecole Normale Sup\u00e9rieure de Lyon, Univ Lyon, Lyon, France"},{"name":"Universit\u00e9 Claude Bernard Lyon I, Lyon, France"},{"name":"Service d\u2019Hygi\u00e8ne, Epid\u00e9miologie, Infectiovigilance et Pr\u00e9vention, Hospices Civils de Lyon, Lyon, France"},{"name":"\u00c9quipe \u00c9pid\u00e9miologie et Sant\u00e9 Internationale, Laboratoire des Pathog\u00e8nes \u00c9mergents, Fondation M\u00e9rieux, Centre International de Recherche en Infectiologie, Inserm U1111, Centre National de la Recherche Scientifique Unit\u00e9 Mixte de Recherche 5308, Ecole Nationale Sup\u00e9rieure de Lyon, Universit\u00e9 Claude Bernard Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Salles","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Claude Bernard Lyon I, Lyon, France"},{"name":"D\u00e9partement d\u2019H\u00e9matologie Clinique, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Brengel-Pesce","sequence":"additional","affiliation":[{"name":"Joint Research Unit, Hospices Civils de Lyon\/BioMerieux, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Meunier","sequence":"additional","affiliation":[{"name":"Joint Research Unit, Hospices Civils de Lyon\/BioMerieux, Lyon, France"},{"name":"Soladis, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Trouillet-Assant","sequence":"additional","affiliation":[{"name":"CIRI-Centre International de Recherche en Infectiologie, Inserm U1111, Universit\u00e9 Claude Bernard Lyon, CNRS, UMR5308, Ecole Normale Sup\u00e9rieure de Lyon, Univ Lyon, Lyon, France"},{"name":"Universit\u00e9 Claude Bernard Lyon I, Lyon, France"},{"name":"Joint Research Unit, Hospices Civils de Lyon\/BioMerieux, Lyon, France"},{"name":"Virpath, Inserm U1111, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Ader","sequence":"additional","affiliation":[{"name":"D\u00e9partement des Maladies Infectieuses et Tropicales, Hospices Civils de Lyon, Lyon, France"},{"name":"CIRI-Centre International de Recherche en Infectiologie, Inserm U1111, Universit\u00e9 Claude Bernard Lyon, CNRS, UMR5308, Ecole Normale Sup\u00e9rieure de Lyon, Univ Lyon, Lyon, France"},{"name":"Universit\u00e9 Claude Bernard Lyon I, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,2,15]]},"reference":[{"key":"2025121512412968000_9.2.e026093.1","doi-asserted-by":"publisher","DOI":"10.1038\/nri3226"},{"key":"2025121512412968000_9.2.e026093.2","unstructured":"Apperley J , Carreras E , Gluckman E . The 2012 revised edition of the EBMT-ESH handbook on haematopoietic stem cell transplantation. 2012 https:\/\/ebmtonline.forumservice.net."},{"key":"2025121512412968000_9.2.e026093.3","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/bmt.2015.293","article-title":"Hemopoietic stem cell transplantation in thalassemia: a report from the European society for blood and bone marrow transplantation hemoglobinopathy registry, 2000-2010","volume":"51","author":"Baronciani","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"2025121512412968000_9.2.e026093.4","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0b013e328353bc7d"},{"key":"2025121512412968000_9.2.e026093.5","unstructured":"D\u2019Souza A , Fretham C . Current use and outcome of hematopoietic stem cell transplantation: CIBMTR Summary Slides. 2017 https:\/\/www.cibmtr.org\/ReferenceCenter\/SlidesReports\/SummarySlides\/pages \/index.aspx."},{"key":"2025121512412968000_9.2.e026093.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.06.019"},{"key":"2025121512412968000_9.2.e026093.7","unstructured":"Haut Conseil de Sant\u00e9 Publique (HCSP). Vaccination des personnes immunod\u00e9prim\u00e9es ou aspl\u00e9niques. 2014 http:\/\/www.hcsp.fr\/explore.cgi\/avisrapportsdomaine?clefr=504."},{"key":"2025121512412968000_9.2.e026093.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.02.018"},{"key":"2025121512412968000_9.2.e026093.9","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2009.263"},{"key":"2025121512412968000_9.2.e026093.10","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit816"},{"key":"2025121512412968000_9.2.e026093.11","unstructured":"7th European conference on infections in leukaemia guidelines for vaccination of patients with hematological malignancies and HSCT recipients. 2017 http:\/\/www.ecil-leukaemia.com\/telechargements\/ECIL%207%20Vaccine%20Part%20I% 20and%20II%20Final.pdf."},{"key":"2025121512412968000_9.2.e026093.12","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.116772"},{"key":"2025121512412968000_9.2.e026093.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.12.113"},{"key":"2025121512412968000_9.2.e026093.14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1586\/erv.13.35","article-title":"Immunological assessment of influenza vaccines and immune correlates of protection","volume":"12","author":"Reber","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"2025121512412968000_9.2.e026093.15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-2004"},{"key":"2025121512412968000_9.2.e026093.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.12.001"},{"key":"2025121512412968000_9.2.e026093.17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-07-686642"},{"key":"2025121512412968000_9.2.e026093.18","unstructured":"Cordonnier C , Engelhard D , Ljungman P , et al . Definitions of infectious diseases and complications after stem cell transplant, a proposal of infectious diseases working party of the EBMT. 2001 https:\/\/www.ebmt.org\/Contents\/About-EBMT\/Who-We-Are\/ScientificCouncil\/ Documents\/IDWPdefinitions.pdf."},{"key":"2025121512412968000_9.2.e026093.19","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"2025121512412968000_9.2.e026093.20","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ1194"},{"key":"2025121512412968000_9.2.e026093.21","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.065110"},{"key":"2025121512412968000_9.2.e026093.22","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12465"},{"key":"2025121512412968000_9.2.e026093.23","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw158"},{"key":"2025121512412968000_9.2.e026093.24","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.144428"},{"key":"2025121512412968000_9.2.e026093.25","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2008.162"},{"key":"2025121512412968000_9.2.e026093.26","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12363"},{"key":"2025121512412968000_9.2.e026093.27","first-page":"12","article-title":"ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients","volume":"73","author":"Cesaro","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2025121512412968000_9.2.e026093.28","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12022"},{"key":"2025121512412968000_9.2.e026093.29","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12054"},{"key":"2025121512412968000_9.2.e026093.30","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis844"},{"key":"2025121512412968000_9.2.e026093.31","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287"},{"key":"2025121512412968000_9.2.e026093.32","doi-asserted-by":"publisher","DOI":"10.1086\/317471"},{"key":"2025121512412968000_9.2.e026093.33","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/161.4.728"},{"key":"2025121512412968000_9.2.e026093.34","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(87)80182-8"},{"key":"2025121512412968000_9.2.e026093.35","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.10.2.202-207.2003"},{"key":"2025121512412968000_9.2.e026093.36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198406143102404"},{"key":"2025121512412968000_9.2.e026093.37","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1164\/ajrccm.162.4.9910088","article-title":"Utility of the antibody response to a conjugated haemophilus influenzae type b vaccine for diagnosis of primary humoral immunodeficiency","volume":"162","author":"Rodrigo","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2025121512412968000_9.2.e026093.38","unstructured":"World Health Organization. Health topics: Immunization. 2018 http:\/\/www.who.int\/topics\/immunization\/en\/."},{"key":"2025121512412968000_9.2.e026093.39","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.cmi.2017.06.023","article-title":"Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation-a position paper","volume":"23","author":"Sarmati","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"2025121512412968000_9.2.e026093.40","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015734","article-title":"The REAnimation Low Immune Status Markers (REALISM) project: a protocol for broad characterisation and follow-up of injury-induced immunosuppression in intensive care unit (ICU) critically ill patients","volume":"7","author":"Rol","year":"2017","journal-title":"BMJ Open"},{"key":"2025121512412968000_9.2.e026093.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.03.002"},{"key":"2025121512412968000_9.2.e026093.42","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1016\/j.celrep.2016.08.011","article-title":"Standardized whole-blood transcriptional profiling enables the deconvolution of complex induced immune responses","volume":"16","author":"Urrutia","year":"2016","journal-title":"Cell Rep"},{"key":"2025121512412968000_9.2.e026093.43","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jim.2014.10.006","article-title":"Flow cytometric evaluation of lymphocyte transformation test based on 5-ethynyl-2\u2019deoxyuridine incorporation as a clinical alternative to tritiated thymidine uptake measurement","volume":"415","author":"Poujol","year":"2014","journal-title":"J Immunol Methods"},{"key":"2025121512412968000_9.2.e026093.44","unstructured":"Machin D , Campbell MJ , Tan SB , et al . Comparing two independent groups for binary data. Sample Size Tables for Clinical Studies. 3 edn, 2011:30\u201341."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2018-026093","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T20:41:41Z","timestamp":1765831301000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2018-026093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,2,15]]},"published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.1136\/bmjopen-2018-026093"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2018-026093","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}